Anticancer Therapy
Interleukin-18 inhibits osteosarcoma metastasis partly via cell mobility suppression
Published in Blood Weekly, August 17th, 2006
According to a study from Japan, "The effect of interleukin-18 (IL-18) on metastasis of highly metastatic LM8 mouse osteosarcoma cells was investigated using nude mice treated with antiasialo GM1 serum to exclude antitumor actions of IL-18 through activation of T and natural killer cells."
Y. Nakamura and colleagues at Hyogo Medical University reported, "Injection of LM8 cells which do not express IL-18 receptor beta into a tail vain resulted in the formation of pulmonary and hepatic metastatic foci.
"Daily...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-08-17)
More Articles from Blood Weekly
- Artificial Liver
Solution preserves urea cycle enzymes in hepatocytes - Cardiovascular Research
Endotoxic shock-associated hemodynamics may be improved with large-pore membrane hemofiltration - Developmental Biology
Growth and osteogenic differentiation of bone marrow stromal cells characterized - Tissue Engineering
Skin preserved long-term in anhydric sodium chloride resumes function after transplantation - Alzheimer Disease
Exelon Patch, first transdermal therapy for Alzheimer disease, may provide new treatment approach - Angiology
Femoral arterial occlusive disease successfully treated with Hemobahn/Viabahn endoprostheses - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
